MSL
IMGN

Mackay Shields LLC’s Immunogen Inc IMGN Stock Holding History

Mackay Shields LLC’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-66,110
Closed -$179K – 1532
2019
Q1 		$179K Hold
66,110
– – ﹤0.01% 1349
2018
Q4 		$317K Buy
66,110
+10,310
+18% +$62.6K ﹤0.01% 1240
2018
Q3 		$528K Buy
55,800
+10,100
+22% +$97.1K ﹤0.01% 995
2018
Q2 		$445K Buy
+45,700
New +$482K ﹤0.01% 1116

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's IMGN Position: Q2 2019 in Review

Mackay Shields LLC sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 66,110 shares — an estimated $179K sold.

Mackay Shields LLC first reported a position in IMGN in Q2 2018 and held it in 4 quarters. The position peaked at $528K in Q3 2018. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Mackay Shields LLC reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 66,110 Immunogen Inc shares in Q2 2019, an estimated $179K.
  • Mackay Shields LLC first reported a position in Immunogen Inc in Q2 2018 and held it in 4 quarters.
  • Mackay Shields LLC's Immunogen Inc position peaked at $528K in Q3 2018.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Mackay Shields LLC's 13F filing for Q2 2019, filed 13 Aug 2019.